ANG Lifesciences India Limited (BOM:540694)

ANG Lifesciences India Statistics

Total Valuation

BOM:540694 has a market cap or net worth of INR 324.11 million. The enterprise value is 1.19 billion.

Market Cap	324.11M
Enterprise Value	1.19B

Important Dates

The next estimated earnings date is Friday, February 13, 2026.

Earnings Date	Feb 13, 2026
Ex-Dividend Date	n/a

Share Statistics

BOM:540694 has 13.06 million shares outstanding. The number of shares has decreased by -0.45% in one year.

Current Share Class	13.06M
Shares Outstanding	13.06M
Shares Change (YoY)	-0.45%
Shares Change (QoQ)	-0.31%
Owned by Insiders (%)	72.40%
Owned by Institutions (%)	n/a
Float	3.60M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	0.35
PB Ratio	0.55
P/TBV Ratio	0.55
P/FCF Ratio	11.49
P/OCF Ratio	6.72
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	-9.73
EV / Sales	1.29
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	42.08

Financial Position

The company has a current ratio of 1.06, with a Debt / Equity ratio of 1.52.

Current Ratio	1.06
Quick Ratio	0.53
Debt / Equity	1.52
Debt / EBITDA	n/a
Debt / FCF	31.86
Interest Coverage	-0.98

Financial Efficiency

Return on equity (ROE) is -18.75% and return on invested capital (ROIC) is -5.71%.

Return on Equity (ROE)	-18.75%
Return on Assets (ROA)	-2.12%
Return on Invested Capital (ROIC)	-5.71%
Return on Capital Employed (ROCE)	-11.43%
Weighted Average Cost of Capital (WACC)	6.39%
Revenue Per Employee	2.24M
Profits Per Employee	-296,228
Employee Count	412
Asset Turnover	0.38
Inventory Turnover	1.17

Taxes

Income Tax	-40.15M
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -42.46% in the last 52 weeks. The beta is -0.13, so BOM:540694's price volatility has been lower than the market average.

Beta (5Y)	-0.13
52-Week Price Change	-42.46%
50-Day Moving Average	28.35
200-Day Moving Average	29.38
Relative Strength Index (RSI)	33.99
Average Volume (20 Days)	6,690

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, BOM:540694 had revenue of INR 922.09 million and -122.05 million in losses. Loss per share was -9.39.

Revenue	922.09M
Gross Profit	316.44M
Operating Income	-82.48M
Pretax Income	-162.19M
Net Income	-122.05M
EBITDA	-31.83M
EBIT	-82.48M
Loss Per Share	-9.39

Balance Sheet

The company has 35.79 million in cash and 898.74 million in debt, with a net cash position of -862.95 million or -66.08 per share.

Cash & Cash Equivalents	35.79M
Total Debt	898.74M
Net Cash	-862.95M
Net Cash Per Share	-66.08
Equity (Book Value)	590.08M
Book Value Per Share	44.85
Working Capital	103.31M

Cash Flow

In the last 12 months, operating cash flow was 48.24 million and capital expenditures -20.03 million, giving a free cash flow of 28.21 million.

Operating Cash Flow	48.24M
Capital Expenditures	-20.03M
Free Cash Flow	28.21M
FCF Per Share	2.16

Margins

Gross margin is 34.32%, with operating and profit margins of -8.95% and -13.24%.

Gross Margin	34.32%
Operating Margin	-8.95%
Pretax Margin	-17.59%
Profit Margin	-13.24%
EBITDA Margin	-3.45%
EBIT Margin	-8.95%
FCF Margin	3.06%

Dividends & Yields

BOM:540694 does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	0.45%
Shareholder Yield	0.45%
Earnings Yield	-37.66%
FCF Yield	8.70%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

The last stock split was on July 13, 2022. It was a forward split with a ratio of 1.25.

Last Split Date	Jul 13, 2022
Split Type	Forward
Split Ratio	1.25

Scores

Altman Z-Score	n/a
Piotroski F-Score	3